Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-20
2010-06-01
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S347100, C548S355100
Reexamination Certificate
active
07728028
ABSTRACT:
Substituted imidazoline derivatives corresponding to Formula I:a method for producing them from substituted aldehyde compounds of Formula B:and the use of such imidazoline derivatives and aldehyde compounds to treat pain, depression, urinary incontinence, diarrhea, pruritus, alcohol and drug misuse, drug dependency, lethargy and/or anxiety.
REFERENCES:
patent: 6673794 (2004-01-01), Puetz et al.
patent: 7608619 (2009-10-01), Merla et al.
patent: 1 486 490 (2004-12-01), None
patent: WO 99/09829 (1999-03-01), None
patent: WO 99/09979 (1999-03-01), None
patent: WO 01/49654 (2001-07-01), None
patent: WO 03/101969 (2003-12-01), None
International Search Report dated May 8, 2007 (one (1) page).
Englberger Werner
Graubaum Heinz
Hennies Hagen-Heinrich
Merla Beatrix
Oberboersch Stefan
Crowell & Moring LLP
Gruenenthal GmbH
Saeed Kamal A
LandOfFree
Substituted imidazoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235005